Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Teva_Pharmaceutical_Industries
|
| gptkbp:acquisitionYear |
2008
|
| gptkbp:ceased_operations |
2008
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:founded |
1970
|
| gptkbp:founder |
gptkb:Edwin_A._Cohen
|
| gptkbp:headquartersLocation |
gptkb:Montvale,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Barr Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Plan_B_(emergency_contraceptive)
generic oncology drugs generic oral contraceptives |
| gptkbp:numberOfEmployees |
over 2,000 (at time of acquisition)
|
| gptkbp:parentCompany |
gptkb:Teva_Pharmaceutical_Industries
|
| gptkbp:specializesIn |
generic drugs
|
| gptkbp:stockSymbol |
BRL
|
| gptkbp:tradedOn |
gptkb:New_York_Stock_Exchange
|
| gptkbp:bfsParent |
gptkb:Barr
gptkb:Teva_Pharmaceutical_Industries |
| gptkbp:bfsLayer |
5
|